| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |